Showing results (41-50 of 83) with videos related to
Sort By:
Pageof 9
Revue Medicale De Liege|February 15, 2024
[Mavacamten (Camzyos ®) : first myosin modulator for obstructive hypertrophic cardiomyopathy treatment]Patrizio Lancellotti, Nils de Marneffe, André ScheenExpert Opinion on Medical Diagnostics|March 28, 2013
Critical assessment of diabetic xerosisGérald E Piérard, Claudine Piérard-Franchimont, André ScheenRevue Medicale De Liege|September 15, 2023
[SGLT2 inhibitors : on the borders of diabetology, cardiology, nephrology and… primary care]André Scheen, Patrizio Lancellotti, Pierre Delanaye, et al.American Journal of Clinical Dermatology|June 10, 2004
Acanthosis nigricans associated with insulin resistance : pathophysiology and managementTrinh Hermanns-Lê, André Scheen, Gérald E PiérardStatistical Methods in Medical Research|January 6, 2012
Issues in performing a network meta-analysisStephen Senn, Francois Gavini, David Magrez, et al.Revue Medicale De Liege|June 16, 2025
[Guidelines for the basic management of chronic kidney disease]Pierre Delanaye, Nicolas Paquot, François Jouret, et al.Revue Medicale De Liege|March 15, 2024
[Don't neglect metabolic syndrome]André Scheen, Françoise Luyckx, Nathalie Esser, et al.Revue Medicale De Liege|October 10, 2025
[Semaglutide 2.4 mg (Wegovy®) for the management of clinical obesity with weight-related complications]André Scheen, Nathalie Esser, Jenny De Flines, et al.Revue Medicale De Liege|September 11, 2025
[Biomarkers for an early detection of patients at risk of renal or cardiovascular disease]André Scheen, Pierre Delanaye, François Jouret, et al.Annales D'Endocrinologie|April 10, 2013
[Which anti-tumour benefits to be expected from metformin?]Emmanuel Beck, André J ScheenPageof 9